stock downgrade William Blair Downgrades Lucira Health to Market Perform As a result of the downgrade, the bank also significantly reduced revenue and volume estimates for 2021 and 2022. Roche to Acquire GenMark Diagnostics for $1.8B Under the acquisition agreement, expected to close in Q2, Roche will acquire all outstanding shares of GenMark's common stock for $24.05 per share. Oppenheimer Downgrades Invitae to Perform Rating Although Oppenheimer raised its price target from $48 to $51 in early January, the investment firm sees "increased risk of underperformance for Invitae shares." Evercore ISI Downgrades Twist Bioscience to In-Line Rating The investment bank said that while Twist's biopharma and DNA-based data storage businesses offer upside, the timelines for generating revenues are unclear. BTIG Downgrades Fulgent Genetics from Buy to Neutral The investment bank said it expects demand for Fulgent's COVID-19 testing to decline over the next two years. Oct 14, 2020 JP Morgan Rates Invitae Neutral Oct 1, 2020 Amid Volatile Markets, GenomeWeb Index Up 3 Percent in September Sep 22, 2020 UBS Downgrades Illumina to Neutral; Expresses Doubts About Grail Deal Jul 1, 2020 OncoCyte Downgraded to Neutral by Piper Sandler on Unsuccessful Results for Lung Cancer Test Feb 3, 2020 Illumina Stock Drags GenomeWeb Index Down in January Jan 2, 2020 Qiagen Stock Tanks in December, Fluidigm Shares Soar as GenomeWeb Index Ends 2019 on High Note Jan 2, 2020 Evercore ISI Upgrades PerkinElmer, Downgrades Hologic Jan 2, 2020 Illumina Stock Downgraded to 'In-Line' by Evercore ISI Dec 11, 2019 GenMark Diagnostics Downgraded by JP Morgan to Neutral Oct 9, 2019 Waters Stock Downgraded by Barclays Sep 27, 2019 Luminex, Accelerate Diagnostics Downgraded by JP Morgan to Underweight Jul 16, 2019 Qiagen Stock Downgraded to 'In Line' by Evercore ISI Jul 9, 2019 Cowen Downgrades Myriad Genetics' Stock Jan 5, 2018 William Blair Downgrades Illumina to Market Perform Dec 13, 2017 JP Morgan Downgrades Genomic Health to Underweight Oct 12, 2017 Cowen Downgrades NanoString to Market Perform on Preannouncement of 'Huge Q3 Miss' May 3, 2017 Raymond James Downgrades Genomic Health to Market Perform Apr 19, 2017 Cantor Fitzgerald Downgrades PerkinElmer to Neutral Jan 4, 2017 Barclays Upgrades Agilent, Downgrades Bruker Aug 4, 2016 PerkinElmer Q2 Revenues Up 2 Percent; Discloses Bioo Scientific Acquisition Load More Breaking News Beckman Coulter, Invitae Partner to Develop NGS Library Prep Applications Sick Infants Profiled with WGS See Better Diagnosis, More Care Changes UC Santa Cruz Center for Live Cell Genomics Wins $13.5M NIH Grant Genetron Health, Impact Therapeutics Partner for Anti-Cancer Drug, CDx Development Canaccord Genuity Initiates Coverage of Pacific Biosciences With Buy Rating Alternative Genetic Counseling Approach Leads to Higher Patient Satisfaction, Study Suggests The Scan Highly Similar Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News. Gain of Oversight According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research. Lasker for mRNA Vaccine Work The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.